| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/07/2009 | WO2008112543A3 Rat, rabbit, and cynomolgus monkey il-21 and il-22 nucleotide and polypeptide sequences |
| 05/07/2009 | WO2008112475A3 Protein sweetener |
| 05/07/2009 | WO2008104830A3 Non-invasive real-time in vivo bioluminescence imaging of local ca 2+ dynamics in living organisms |
| 05/07/2009 | WO2008098995A3 Genes involved in mitochondrial biogenesis |
| 05/07/2009 | WO2008085564A3 Compositions and methods involving truncated recombinant seven g-protein coupled receptors |
| 05/07/2009 | WO2008019735A9 Determination of renin/prorenin receptor activity |
| 05/07/2009 | WO2007122400A9 Novel polypeptides and use thereof |
| 05/07/2009 | WO2007100357A3 Stem cell factor-like protein scfa1 and uses thereof |
| 05/07/2009 | WO2007059297A3 Multimeric biosensors and methods of using the same |
| 05/07/2009 | WO2007056039A3 Therapies for seizure disorders using rlip76 |
| 05/07/2009 | WO2007051063A3 Gpcr expressing cell lines and antibodies |
| 05/07/2009 | WO2007027910A3 Peptide mimics of melanocyte stimulating hormone |
| 05/07/2009 | WO2006135739A3 A novel conotoxin framework with a helix-loop-helix fold |
| 05/07/2009 | WO2006133098A3 Pharmacological chaperones for treating obesity |
| 05/07/2009 | WO2006073587A3 Hemipteran 5-hydroxytryptamine 7 serotonin receptor |
| 05/07/2009 | WO2006073417A3 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 05/07/2009 | WO2006006166A3 Implantable power sources and sensors |
| 05/07/2009 | US20090119797 Gro-1 herbicide resistance gene and methods for its use |
| 05/07/2009 | US20090119793 Plant Defense Signal Peptides |
| 05/07/2009 | US20090119019 Small Molecule Mimetics of Erythropoietin |
| 05/07/2009 | US20090118486 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 05/07/2009 | US20090118483 Light-driven energy generation using proteorhodopsin |
| 05/07/2009 | US20090118481 High Affinity Nucleic Acid Ligands To Lectins |
| 05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
| 05/07/2009 | US20090118474 Method and composition for crystallizing G protein-coupled receptors |
| 05/07/2009 | US20090118473 MN Gene and Protein |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118468 Immunotherapy of prostate, including hormone-refractory prostate cancer (HRPC), and breast cancer; vaccines |
| 05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
| 05/07/2009 | US20090118217 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 05/07/2009 | US20090118212 Methods for producing and using in vivo pseudotyped retroviruses |
| 05/07/2009 | US20090118210 Epididymal lipocalin gene and uses thereof |
| 05/07/2009 | US20090118209 Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications |
| 05/07/2009 | US20090118195 Molecules Which Promote Hematopoiesis |
| 05/07/2009 | US20090118191 Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF) |
| 05/07/2009 | US20090118190 Muteins of fibroblast growth factor 21 |
| 05/07/2009 | US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/07/2009 | US20090118186 administering to a cancer patient a soluble tumor necrosis factor related apoptosis inducing ligand (TRAIL) polypeptide, selected from the extracellular domain of human TRAIL or fragment thereof, in the form of an oligomer; treatment of leukemia, melanoma or lymphoma |
| 05/07/2009 | US20090118185 Recombinant factor viii having reduced inactivation by activated protein c |
| 05/07/2009 | US20090118184 Recombinant factor viii having increased stability |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118181 Compositions and methods for producing bioactive fusion proteins |
| 05/07/2009 | US20090118180 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 05/07/2009 | US20090118178 Y4 selective receptor agonists for therapeutic interventions |
| 05/07/2009 | US20090118174 Novel peptides and methods for the treatment of inflammatory disorders |
| 05/07/2009 | US20090118172 Shortened glucagon-like peptide 1(sglp-1) preparation method and application |
| 05/07/2009 | US20090118171 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 05/07/2009 | US20090118167 Selective Vpac2 Receptor Peptide Agonists |
| 05/07/2009 | US20090118142 Method and agent for immobilizing protein via protein bound to silicon oxide-containing substance |
| 05/07/2009 | US20090117662 Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof |
| 05/07/2009 | US20090117618 Expression system for preparing IL-15/FC fusion protein and its use |
| 05/07/2009 | US20090117595 Primary central nervous system tumor specific behab isoforms |
| 05/07/2009 | US20090117593 T. Cruzi-derived neurotrophic agents and methods of use therefor |
| 05/07/2009 | US20090117590 Human calcium sensitive potassium channel beta3 subunit proteins, encoding nucleic acid and uses thereof |
| 05/07/2009 | US20090117587 for binding epitopes of Clostridium botulinum neurotoxin (BoNT) type A and hybridomas that produce such antibodies; kit for detecting BoNT/A |
| 05/07/2009 | US20090117586 Fungal cell wall synthesis gene |
| 05/07/2009 | US20090117583 EGF-like nucleic acids and polypeptides and uses thereof |
| 05/07/2009 | US20090117572 Modified cells comprising clostridial toxin substrate for use in diagnosing grampositive bacterial infection; screening for neuroparalytic and botulin syndromes |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117564 Estrogen receptor genes and utilization thereof |
| 05/07/2009 | US20090117563 Identification of TRPML3 (MCOLN3) as a Salty Taste Receptor and Use in Assays for Identifying Taste (Salty) Modulators and/or Therapeutics that Modulate Sodium Transport, Absorption or Excretion and/or Aldosterone and/or Vasopressin Production or Release |
| 05/07/2009 | US20090117554 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic uses |
| 05/07/2009 | US20090117547 NOVEL HAPLOTYPE OF HUMAN T2R RECEPTOR hT2R50 AND ITS USE IN ASSAYS FOR IDENTIFYING HUMAN BITTER TASTE MODULATORS |
| 05/07/2009 | US20090117543 Methods and compositions for inducing sirtuins |
| 05/07/2009 | US20090117538 Methods for Obtaining Gene Tags |
| 05/07/2009 | US20090117231 Soy Protein Composition and Beverage Products Containing the Soy Protein Composition |
| 05/07/2009 | US20090117227 Gene encoding trehalose-6-phosphate phosphatase and use thereof |
| 05/07/2009 | US20090117178 with immunogenic or therapeutic properties against ischemic cardiovascular diseases; atherosclerosis |
| 05/07/2009 | US20090117169 Methods and compositions for regulating proliferation and migration of vascular smooth muscle cells |
| 05/07/2009 | US20090117153 Disulfide Trap MHC Class I Molecules and Uses Therefor |
| 05/07/2009 | US20090117151 for preparing a vaccine which contains one or more than two genes among pgs B, pgs C and pgs A encoding poly- gamma -glutamate synthetase complex and genes selected from human papilloma virus (HPV) E6 and HPV E7 antigen protein associated with tumor induction; genital wash |
| 05/07/2009 | US20090117150 Functional Mutations In Respiratory Syncytial Virus |
| 05/07/2009 | US20090117145 Composition and Method For Enhancing Immune Response |
| 05/07/2009 | US20090117144 Recombinant flu vaccines |
| 05/07/2009 | US20090117142 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
| 05/07/2009 | US20090117140 Human papilloma virus dominant CD4 T cell epitopes and uses thereof |
| 05/07/2009 | US20090117139 Lutzomyia longipalpis polypeptides and methods of use |
| 05/07/2009 | US20090117137 Peptide epitopes of apolipoprotein b |
| 05/07/2009 | US20090117136 Recombinant allergen |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117130 Kallikrein-inhibitor therapies |
| 05/07/2009 | US20090117123 Immunopeptides of hpv e6 and e7 proteins |
| 05/07/2009 | US20090117121 Pseudomonas Aeruginosa Outer Membrane Protein PA0427 |
| 05/07/2009 | US20090117119 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 05/07/2009 | US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/07/2009 | US20090117115 Binary epitope antibodies and B cell superantigen immune stimulants |
| 05/07/2009 | US20090117114 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/07/2009 | US20090117104 Glucagon-like peptide-2 (GLP-2); treating inflammatory ileus |
| 05/07/2009 | US20090117101 HEH4 Molecules and Uses Thereof |
| 05/07/2009 | US20090117095 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090117036 Antibodies against gpr64 and uses thereof |
| 05/07/2009 | US20090117032 Imaging Agents for Early Detection and Monitoring of Cardiovascular Plaque |
| 05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
| 05/07/2009 | DE10010113B4 Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung Native collagen sponge, process for its isolation and its use, as well as native nanoparticulate sponge collagen, process for its preparation and its use |
| 05/07/2009 | CA2805976A1 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | CA2707861A1 Glucagon antagonists |
| 05/07/2009 | CA2704786A1 Materials and methods for gene mediated therapy of psychiatric disorders |